Should We Finalize TAVR with Atrial Pacing in Some Patients?

Courtesy of Dr. Carlos Fava.

The benefits of transcatheter aortic valve replacement (TAVR) are undoubtedly clear, but implantation is performed near the atrioventricular (AV) node, the bundle of His, and the left bundle branch. Consequently, permanent pacemaker implantation (PPI) after TAVR or surgical aortic valve replacement becomes necessary.

¿Debemos finalizar el TAVI con marcapaseo auricular en algunos pacientes?

While researchers have recently developed strategies to reduce the need for PPI, it still has not been entirely shown who would require a pacemaker. In that sense, there is no fast and safe test to establish what patients need it, because currently we only have risk stratification criteria such as complete right bundle branch block, new left bundle branch block, complete AV block during the procedure, severe calcification, and valve type.

In this study, after valve implantation, the temporary pacemaker was withdrawn from the right ventricle and placed in the right atrium. Rapid atrial pacing was performed from 70 to 120 beats/min or until there was a complete AV block. The Wenckebach phenomenon was defined as a prolongation of the P-R segment during pacing, until there was a complete QRS block.

The study enrolled 284 patients. Among them, 130 experienced the Wenckebach phenomenon.


Read also: Tricuspid valve: Is Percutaneous Intervention Feasible in Patients with Definite Pacemaker?


Both patient groups were similar: the age was 81 years old, 45% were women, 32% had diabetes, and there were no differences as regards New York Heart Association functional class. The Society of Thoracic Surgeons (STS) score was 5.6. End-stage renal failure was more frequent in patients who did not experience the Wenckebach phenomenon (3.2% vs. 0%; p = 0.0032), and first-degree AV block was more common in patients with the Wenckebach phenomenon (36.7% vs. 16.8%; p < 0.001).

There was no pericardial effusion, tamponade, or any other complications during atrial pacing. There was no difference either as regards 30-day complications between groups.

The need for permanent pacemaker at 30 days was higher among patients who experienced the Wenckebach phenomenon (13.1% vs. 1.3%; p < 0.001), with a 98.7% negative predictive value for permanent pacemaker.


Read also: TAVR and Pacemakers, New Strategies.


The need for permanent pacemaker was higher in patients with balloon-expandable valves (15.9% vs. 3.7%; p < 0.001), but it was very low in those who did not develop Wenckebach (2.9% and 0.8%).

Conclusion

Atrial pacing after TAVR is easily performed and can help identify patients who may benefit from temporary rhythm monitoring. Patients who did not develop pacing-induced Wenckebach phenomenon have a very low likelihood of permanent pacemaker implantation.

Courtesy of Dr. Carlos Fava.

Original Title: The Utility of Rapid Atrial Pacing Immediately Post-TAVR to Predict the Need for Pacemaker Implantation.

Reference: Amar Krishnaswamy, et al. J Am Coll Cardiol Intv 2020;13:1046-1054.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

ACC 2026 | Extended follow-up of the TRI-FR study: Edge-to-edge percutaneous repair in isolated severe tricuspid regurgitation

Severe tricuspid regurgitation (TR) is associated with chronic systemic venous congestion, recurrent hospitalizations for heart failure (HF), and a significant deterioration in quality of...

ACC 2026 | Protect The Head-To-Head Trial: Randomized Comparison Between Emboliner and Sentinel During TAVI

Ischemic stroke remains one of the most feared complications of TAVI, with a relatively low but persistent incidence of 2–4%, without significant reduction over...

ACC 2026 | PRO-TAVI Trial: Deferring Coronary Angioplasty in Patients Undergoing TAVI

Coronary artery disease is common in patients with severe aortic stenosis undergoing TAVI. Current guidelines recommend considering revascularization in significant coronary lesions, particularly in...

ACC 2026 | CHAMPION-AF: Left atrial appendage closure versus anticoagulation in atrial fibrillation

Can left atrial appendage closure challenge anticoagulation as the standard of care in atrial fibrillation? Atrial fibrillation (AF) is the most common sustained arrhythmia and...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC 2026 | Extended follow-up of the TRI-FR study: Edge-to-edge percutaneous repair in isolated severe tricuspid regurgitation

Severe tricuspid regurgitation (TR) is associated with chronic systemic venous congestion, recurrent hospitalizations for heart failure (HF), and a significant deterioration in quality of...

ACC 2026 | SirPAD Trial: Sirolimus-coated balloon angioplasty in infrainguinal arterial disease

Paclitaxel-coated balloons have demonstrated improved patency in peripheral arterial disease (PAD), although questions remain regarding safety and applicability across different vascular territories. In this...

ACC 2026 | IVUS-CHIP Trial: Intravascular ultrasound–guided versus angiography-guided complex PCI

Optimization of percutaneous coronary intervention (PCI) in complex lesions remains a relevant clinical challenge. In this context, the IVUS-CHIP trial was designed to evaluate...